{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:47:08Z","timestamp":1791488828858,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.humpath.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T01:16:13Z","timestamp":1513041373000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin"],"prefix":"10.1016","volume":"73","author":[{"given":"Jau-Yu","family":"Liau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Huei","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Bon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Tsu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.12.002_bb0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/archderm.1977.01640050056005","article-title":"Papillary eccrine adenoma","volume":"113","author":"Rulon","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0560.1976.tb00850.x","article-title":"Tubular apocrine adenoma","volume":"3","author":"Umbert","year":"1976","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0560.1989.tb00047.x","article-title":"A case of tubular apocrine adenoma with syringocystadenoma papilliferum","volume":"16","author":"Ansai","year":"1989","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000372-199604000-00001","article-title":"A call for logic in the classification of adnexal neoplasms","volume":"18","author":"McCalmont","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000372-199604000-00004","article-title":"Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases","volume":"18","author":"Wong","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00000372-199510000-00012","article-title":"Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?","volume":"17","author":"Tellechea","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1034\/j.1600-0560.2003.00031.x","article-title":"Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor","volume":"30","author":"Hsu","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.2316","article-title":"Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome","volume":"44","author":"Groesser","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2017.12.002_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/his.13043","article-title":"Frequent PIK3CA activating mutations in nipple adenomas","volume":"70","author":"Liau","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2017.12.002_bb0050","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/jid.2015.180","article-title":"Somatic V600E BRAF mutation in linear and sporadic syringocystadenoma papilliferum","volume":"135","author":"Levinsohn","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.humpath.2014.11.002","article-title":"Activating mutations in the RAS\/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum","volume":"46","author":"Shen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0060","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAS.0000000000000734","article-title":"Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary Glands","volume":"41","author":"Bishop","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0075","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2017.12.002_bb0080","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/PAS.0000000000000463","article-title":"Detection of MYB alterations and other immunohistochemical markers in primary cutaneous adenoid cystic carcinoma","volume":"39","author":"North","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/gcc.20168","article-title":"Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)--associated TORC1-MAML2 gene fusion","volume":"43","author":"Behboudi","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2017.12.002_bb0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/gcc.20440","article-title":"Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas","volume":"46","author":"Winnes","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2017.12.002_bb0095","series-title":"WHO Classification of Tumours of the Breast","first-page":"150","article-title":"Tumours of the nipple","author":"Eusebi","year":"2012"},{"key":"10.1016\/j.humpath.2017.12.002_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.22315","article-title":"Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma","volume":"55","author":"Pfarr","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2017.12.002_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2016.04.014","article-title":"Frequent PIK3CA activating mutations in hidradenoma papilliferums","volume":"55","author":"Liau","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0110","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/modpathol.2013.197","article-title":"Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions","volume":"27","author":"Ang","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/modpathol.2009.142","article-title":"High prevalence of PIK3CA\/AKT pathway mutations in papillary neoplasms of the breast","volume":"23","author":"Troxell","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4103\/0378-6323.51250","article-title":"Giant condyloma acuminata with syringocystadenoma papilliferum","volume":"75","author":"Sardesai","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1600-0560.2003.300106.x","article-title":"Syringocystadenoma papilliferum contiguous to a verrucous cyst","volume":"30","author":"Li","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1034\/j.1600-0560.2000.027004199.x","article-title":"Mixed syringocystadenoma papilliferum and papillary eccrine adenoma occurring in a scrotal condyloma","volume":"27","author":"Coyne","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0135","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.13143","article-title":"Frequent activating HRAS mutations in trichilemmoma","volume":"171","author":"Tsai","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/1346-8138.13153","article-title":"Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi","volume":"43","author":"Igawa","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PAS.0000000000000547","article-title":"\u201cApocrine hidrocystoma and cystadenoma\"-like tumor of the digits or toes: a potential diagnostic pitfall of digital papillary adenocarcinoma","volume":"40","author":"Molina-Ruiz","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anndiagpath.2015.08.002","article-title":"Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma","volume":"19","author":"Bell","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.humpath.2015.12.015","article-title":"Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations","volume":"51","author":"Harms","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/JID.2015.376","article-title":"BRAF and RAS mutations in sporadic and secondary pyogenic granuloma","volume":"136","author":"Groesser","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0165","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/PAS.0000000000000913","article-title":"BRAF V600E mutations occur in a subset of glomus tumors, and are associated with malignant histologic characteristics","volume":"41","author":"Karamzadeh Dashti","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.12.002_bb0170","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.12.002_bb0175","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1046\/j.1523-1747.2003.12559.x","article-title":"Mutations of the BRAF gene in benign and malignant melanocytic lesions","volume":"121","author":"Yazdi","year":"2003","journal-title":"J Invest Dermatol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T04:48:49Z","timestamp":1603514929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717304677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":35,"alternative-id":["S0046817717304677"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.12.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}